Of course a $2-$3mln commitment for them is small, that's not the point, the point is the hottest Biotech investors are in, why are they in at all? Maybe this is just a starter position and we see adds this quarter? There are hundreds of other choices to plunk $ down in, why Mast? Baker Bros doesn't play lotto games,they make very calculated choices. Maybe their Biostatistician reviewed the past trials, saw the EPIC redesign and ran a Monte Carlo simulation and liked what he saw?
News 
Market Data 
Discover 
